Super League Enterprise, Inc. creates and publishes content experiences and media solutions across immersive platforms in the United States and internationally. Its proprietary cloud-based platform ...
The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.
Data suggest incidence and prevalence of systemic lupus erythematosus (SLE) vary widely among regions, although the authors noted some regions have been studied more extensively than others. A new ...
Dendritic cells (DCs) are key mediators of the balance between autoimmunity and tolerance, and have been described as the cells that link innate and adaptive immunity as they are the only cell type ...
Background Although the increased risk of cardiovascular disease in patients with SLE is well-documented, effective tools for ...
Systemic lupus erythematosus (SLE) is the most common type of lupus, a chronic autoimmune disease. Symptoms include fatigue, joint pain, and rashes across your nose and cheeks. While there’s no cure, ...
Please provide your email address to receive an email when new articles are posted on . Risks were particularly high in women who received both systemic and local hormone therapies. Future studies ...
Systemic lupus erythematosus (SLE) is the most common form of lupus — it’s the type that 7 in 10 people with lupus have. It's what most people mean when they say "lupus." Experts don’t know what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results